MariMed Inc. · CSE:MRMD

MariMed — Q3 2026 Earnings Presentation

20 slides from MariMed's earnings presentation, November 2026

  1. Slide 1: Investor Presentation with Q3 2026 Financial Highlights

    INVESTOR PRESENTATION WITH Q3 2026 FINANCIAL HIGHLIGHTS

  2. Slide 2: Forward Looking Statement Disclaimer

    Forward Looking Statement Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This presentation includes information, statements, beliefs, and opinions which are forward-looking, and which reflect current estimates, expectations, and projections about future events, referred to herein

  3. Slide 3: We're on a Mission to Improve Lives Through the Power of Cannabis

    We’re on a Mission to Improve Lives Through the Power of Cannabis. 3

  4. Slide 4: Our Growth Strategy

    OUR GROWTH STRATEGY • Grow MariMed’s portfolio • Expand wholesale • Increase customer lifetime of leading cannabis brands penetration and asset-light value through retail Scale Distribution through innovation, market expansion through engagement, loyalty Expand the Brand Deepen Consumer category exp

  5. Slide 5: MariMed by the Numbers

    MARIMED BY THE NUMBERS $160M 900+ 8 14 2025 REVENUE EMPLOYEES STATES DISPENSARIES inc. footprint + licensing partnerships 7 52M+ 720+ 5 FACILITIES Cultivation and POPULATION WHOLESALE BRANDS Production ACCOUNTS #1 Edible & #4 Beverage Across Core States ~526K+ sq ft (inc. PA facility under Mgmt.) ~$

  6. Slide 6: Why MariMed Wins

    WHY MARIMED WINS Leading Cannabis CPG Platform Scalable Wholesale Engine Retail + Loyalty Ecosystem • #1 edible brand across core markets • 64% dispensary penetration • 432K loyalty members • Expanding beverage leadership • 720+ wholesale accounts • 80% of retail revenue tied to members • Portfolio

  7. Slide 7: Wholesale: Driving Our Brand Momentum

    WHOLESALE: DRIVING OUR BRAND MOMENTUM STRONG PERFORMANCE • Wholesale accounted for 44% of 3Q 2026 revenue BRAND PENETRATION • 64% penetration across core states during 3Q 2026 • Brand portfolio market share grew 150 bps STRATEGIC DISTRIBUTION • Product placements in 720+ dispensaries across 6 states

  8. Slide 8: A Portfolio of Top-Selling Brands

    A PORTFOLIO OF TOP-SELLING BRANDS* • Betty’s Eddies™ - #1 edible in MA, MD & DE • Bubby’s Baked™ - #1 baked goods edible in MA, MD & IL • Vibations™ Drink Mix – Top 10 beverage in MA, MD & IL • InHouse™ – Top 10 gummy in MA, MD & DE • Nature's Heritage™ - #1 flower brand in DE *based on BDSA and Lit

  9. Slide 9: Continuing to Expand Across Core Markets

    CONTINUING TO EXPAND ACROSS CORE MARKETS Wholesale Revenue (in millions USD) Doors Coverage Ratio $69.6 $80.0 800 Growth Rate 692 $70.0 $62.9 700 620 $60.0 600 $48.8 $50.0 500 410 $40.0 $32.9 400 $30.0 300 $20.0 200 $10.0 100 $0.0 26% 48% 29% 11% - 55% 83% 85% 2022 2023 2024 2025 2023 2024 2025 85%

  10. Slide 10: Strong Retail Experience

    STRONG RETAIL EXPERIENCE STRONG RETAIL BRAND & PRESENCE • 14 dispensaries across MA, IL, MD, DE, and OH • Strong presence under unified Thrive retail brand, app, and website CONSUMER EXPERIENCE • Curated, wellness-focused retail environments with premium design • Deep community engagement with veter

  11. Slide 11: Strong Loyalty Member Growth

    STRONG LOYALTY MEMBER GROWTH Series1 Members (‘000’s) Series2 Growth 500 450 415 432 Data-Driven Personalization Delivered: 402 400 364 • Membership +31% year to date growth 350 through Q3 2026 300 • Drove 80% of retail revenue in Q3 2026 250 • 1% higher avg basket vs non-members 200 in Q3 2026 150

  12. Slide 12: Management Team

    MANAGEMENT TEAM Jon Levine Timothy Shaw Howard Schacter CEO & President Chief Operating Officer Chief Communications Officer Co-founder of MariMed with two Oversees all cultivation, production, and Veteran communications leader with decades in the cannabis industry. Led retail operations across 9 st

  13. Slide 13: Our Results: Q3 2026 Financial Performance

    OUR RESULTS: Q3 2026 FINANCIAL PERFORMANCE

  14. Slide 14: Q3 2026 Financial Results

    Q3 2026 FINANCIAL RESULTS Revenue & Brand Momentum • Revenue increased 8% year over year to $44.2 million, Revenue $44.2 million despite ongoing industry pricing pressure across several core markets • Wholesale revenue grew 8% year over year, representing GAAP Gross Margin 38.8% 44% of total revenue

  15. Slide 15: Balance Sheet - End of Q3 2026

    BALANCE SHEET - END OF Q3 2026 Capital Structure • Total assets of $198.3 million versus total liabilities of $151.3 million as of quarter-end Cash and Cash Equivalents $10.4 million • Total debt of $78.2 million represented approximately 39% of total assets • Balance sheet capacity continues to sup

  16. Slide 16: Q3 2026 YTD Cash Flow

    Q3 2026 YTD CASH FLOW Cash Flow Category Q3 2026 YTD Activity Positive cash flow Operating Activities $6.654 million from operations Capital expenditures and license Investing Activities -$1.555 million renewals/purchases ~$3.5 million in scheduled Financing Activities -$3.622 million debt and finan

  17. Slide 17: Year-end Non-GAAP Supplemental Information

    Year-end Non-GAAP Supplemental information Income (loss) from Operations to Adjusted EBITDA Reconciliation (in ‘000s USD) 2020 2021 2022 2023 2024 2025 Income (loss) from operations 14,440 26,535 19,879 14,269 2,609 (2,820) Depreciation of property and equipment 1,792 2,098 3,432 5,549 7,910 8,109 A

  18. Slide 18: Q3 2026 Non-GAAP Supplemental Information

    Q3 2026 Non-GAAP Supplemental information (in ‘000s USD, except where noted) GAAP Income from operations 1,221 Depreciation of property and equipment 2,201 Amortization of acquired intangible assets 717 Stock-based compensation 335 Acquisition-related and other 183 Adjusted EBITDA 4,657 GAAP income

  19. Slide 19: Q3 2026 Non-GAAP Supplemental Information

    Q3 2026 Non-GAAP Supplemental information (in ‘000s USD, except where noted) GAAP Net loss (3,487) Stock-based compensation 335 GAAP Gross margin 38.8% Amortization of acquired intangible assets 717 Severance -- Amortization of acquired 1.2% Acquisition-related and other 183 intangible assets Non-GA

  20. Slide 20: Thank You

    THANK YOU For more information: Email: ir@marimedinc.com

MariMed — Q3 2026 Earnings Presentation on 6ix